SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Depotech(depo)
DEPO 7.300+1.7%Aug 14 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: James Silverman who wrote (686)1/8/1998 8:52:00 PM
From: tnsaf  Read Replies (1) of 887
 
I must not have made it clear that MTSL's comment of "not particularly negative" was about the affect on Chiron.

Regarding approval this year: the FDA does not always follow the advice of an advisory committiee, as in the case of Anesta's Atiq. I'm hoping that if DEPO had an agreement with the FDA about what was required for approval and if they have met those requirements, the ODAC rejection would be overridden. I recall that DepoCyte was going to be approved by the end of the year if an ODAC meeting could not be scheduled. I'm waiting to see.

Jason
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News